References
- PalumboAAndersonKMultiple myelomaN Engl J Med2011364111046106021410373
- PalumboACavalloFHave drug combinations supplanted stem cell transplantation in myeloma?Blood2012120244692469822730541
- RichardsonPGHideshimaTMitsiadesCAndersonKCThe emerging role of novel therapies for the treatment of relapsed myelomaJ Natl Compr Canc Netw20075214916217335684
- SonneveldPBroijlATreatment of relapsed and refractory multiple myelomaHaematologica2016101439640627033237
- GertzMAWitzigTEPinedaAAGreippPRKyleRALitzowMRMonoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantationBone Marrow Transplant19971943373429051243
- VogelWKoppHGKanzLEinseleHMyeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantationJ Cancer Res Clin Oncol2005131421421815616828
- BasheyAPérezWSZhangMJComparison of twin and autologous transplants for multiple myelomaBiol Blood Marrow Transplant200814101118112418804041
- AlvarnasJCFormanSJGraft purging in autologous bone marrow transplantation: a promise not quite fulfilledOncol Williston Park N200418867876
- DeolaSScaramuzzaSBiroloRSMolecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cellsJ Transl Med2007513517626627
- YangHRobinsonSNNietoYEx vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myelomaCancer Res201171145040504921646477
- ThirukkumaranCMShiZQLuiderJReovirus as a successful ex vivo purging modality for multiple myelomaBone Marrow Transplant2014491808623974608
- HideshimaTRichardsonPChauhanDThe proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cellsCancer Res20016173071307611306489
- AdamsJThe proteasome: structure, function, and role in the cellCancer Treat Rev200329Suppl 139
- DickLRFlemingPEBuilding on bortezomib: second-generation proteasome inhibitors as anti-cancer therapyDrug Discov Today2010155–624324920116451
- MatsuiWWangQBarberJPClonogenic multiple myeloma progenitors, stem cell properties, and drug resistanceCancer Res200868119019718172311
- PalumboAMiguelJSSonneveldPLenalidomide: a new therapy for multiple myelomaCancer Treat Rev200834328329118230411
- KalitinNNKostyukovaMNKakpakovaESTupitsynNNKaramyshevaAFExpression of vascular endothelial growth factor receptors VEGFR1 in cultured multiple myeloma cells: correlation with immunophenotype and drug resistanceBull Exp Biol Med20121536883886